The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis.

By A. Hövels, R. Heesakkers, E. Adang, G. Jager, S. Strum, Y. Hoogeveen, J. Severens, Jelle O. Barentsz. Clinical Radiology, 2008

968 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. (2020, background): “Usually, LNs with a short axis of > 8 mm in the pelvis and > 10 mm outside the pelvis are suspicious for malignancy, with sensitivity below 40% [62].”
ESUR prostate MR guidelines 2012 (2012, background): “Urologists use a lower a priori threshold of 10–17% to perform pelvic lymph node dissection [20].”
EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent. (2024, neutral): “Usually, LNs with a short axis of >8 mm in the pelvis and >10 mm outside the pelvis are suspicious for malignancy, with sensitivity below 40% [50].”
EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. (2011, background): “The decision to proceed with further diagnostic or staging workup is guided by which treatment options are available to the patient, taking the patient’s preference, age, and comorbidity into consideration [34–41].”